Enabling 5T4 for Targeted Cancer Therapy: TUB-030, a Novel ADC Built with Ethynylphosphonamidate Conjugation Chemistry, Shows Long-Lasting Anti-Tumor Activity Via Topoisomerase-I Inhibition with an Optimized Therapeutic Index
Cancer Research(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要